Cargando…
Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
Synthetic lethality is a proven effective antitumor strategy that has attracted great attention. Large-scale screening has revealed many synthetic lethal genetic phenotypes, and relevant small-molecule drugs have also been implemented in clinical practice. Increasing evidence suggests that CDKs, con...
Autores principales: | Li, Kailin, You, Jieqiong, Wu, Qian, Meng, Wen, He, Qiaojun, Yang, Bo, Zhu, Chengliang, Cao, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463275/ https://www.ncbi.nlm.nih.gov/pubmed/34589394 http://dx.doi.org/10.1016/j.apsb.2021.01.002 |
Ejemplares similares
-
Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
por: Kciuk, Mateusz, et al.
Publicado: (2022) -
Synthetic lethal mutations in the cyclin A interface of human cytomegalovirus
por: Weisbach, Henry, et al.
Publicado: (2017) -
Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma
por: Nelson, Luke J, et al.
Publicado: (2022) -
Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation
por: Ford, Kyle, et al.
Publicado: (2023) -
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
por: Dolly, Saoirse O, et al.
Publicado: (2017)